GlassScriptPhysician profile
Kari C Farris
NPI 1558572628
$1,016.62
in general payments reported to CMS, 2019-2025
13 companies · $170 in 2025
The $170 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $145 · 2020: $98.44 · 2021: $129 · 2022: $248 · 2023: $57.85 · 2024: $168 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $396.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $395.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $278.60 | 2019-2022 | |
| Biogen, INC. | $216.28 | 2024-2025 | Zurzuvae |
| Coopersurgical, INC. | $144.38 | 2022-2024 | Paragard T 380a, Fisherbrand Disposable Liquid Infant Heel Warmer, Paragard T 380a |
| Aspira Women'S Health INC | $67.98 | 2022 | |
| Exeltis, USA INC. | $59.29 | 2021-2023 | Slynd |
| Astellas Pharma US INC | $56.15 | 2024-2025 | Veozah |
| Evofem Biosciences, INC. | $43.88 | 2021-2022 | |
| Hologic Sales and Service, LLC | $35.66 | 2022-2024 | Aptima, Thinprep 2000 Processor |
| Bayer Healthcare Pharmaceuticals INC. | $34.79 | 2020 | |
| Agile Therapeutics, INC. | $31.29 | 2022-2023 | Twirla |
| Millicent US INC | $22.51 | 2025 | Femlyv |
| Mayne Pharma Commercial LLC | $13.46 | 2022 | |
| Amag Pharmaceuticals, INC. | $12.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kari Farris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.